Tag: #UNMCID

#PharmToExamTable: Oral Therapy for Gram-Negative Rod (GNR) Bacteremia: Can We Go PO?

The following post exploring a switch from IV to oral antibiotics for treatment of bacteremia was written by Molly Miller, PharmD, ID Pharmacist at Nebraska Medicine.

January 26, 2023

#PharmtoExamTable: The Case for Voriconazole in Histoplasmosis Treatment

A #PharmToExamTable question about the evidence for using voriconazole in disseminated Histoplasmosis infection, answered by Molly Kernan, PharmD, a graduate of the UNMC College of Pharmacy and current pharmacy resident at Nebraska Medicine.

January 12, 2023

Beyond HIV: Applying Long-Acting Formulations to other Infectious Diseases

This post is part of an ongoing series on HIV/AIDS in recognition of HIV/AIDS awareness month 2022. In this series, we focus our posts on education, research, achievements, and medicine pertaining to the HIV/AIDS epidemic. In our previous post, we reviewed the merits of long-acting HIV treatments as a recent breakthrough in HIV/AIDS medical research. […]

December 29, 2022

Long-Acting Formulations of Infectious Disease Treatments

oday, we feature a new supplement in Clinical Infectious Diseases, edited by UNMC ID’s Dr. Susan Swindells. This supplement contains articles chronicling and exploring the use of long-acting formulations in the treatment of infectious diseases.

December 20, 2022

Research Digest: Brains, Bones, and HIV

In this month’s research digest, we will cover recent work by UNMC ID faculty uncovering the link between HIV and various comorbidities associated with infection. HIV research is far from a new topic for this installment (see our previous HIV-focused research digests here and here), which speaks to the commitment of UNMC ID faculty to furthering HIV knowledge and research. Read on for a quick summary of two articles focused on HIV comorbidities dealing with brains and bones, namely HIV-associated neurocognitive disorder and bone fractures.

December 16, 2022

Joint Commission and CMS Conditions of Participation Updates for Antimicrobial Stewardship Programs in Hospitals and Critical Access Hospitals

This post is part of a series on Antibiotic Awareness Week 2022.  For more information, check out the full post on the Nebraska Antimicrobial Stewardship Assessment and Promotion Program (ASAP) blog. Knowing and implementing TJC and CMS requirements for ASPs is essential for a successful program. Furthermore, TJC recommendations are something to take note of […]

November 24, 2022

Sounding the Alarm: Antimicrobial Resistance in the United States

This post is part of a series on Antibiotic Awareness Week 2022, authored by UNMC ID fellow Dr. Mackenzie Keintz. Read on to learn more about growing antimicrobial resistance in the United States and what can be done to stop it.

November 23, 2022

NHSN Antimicrobial Use and Resistance (AUR) Module Reporting – CMS required by 2024!

This post is part of a series on Antibiotic Awareness Week 2022.  For more information, check out the full post on the Nebraska Antimicrobial Stewardship Assessment and Promotion Program (ASAP) blog. Antimicrobial resistance rates continue to increase in hospitals across the United States. One of the five CDC core actions to combat the spread of […]

November 22, 2022

Influential Papers in Antimicrobial Stewardship from the Past Year

This post is part of a series on Antibiotic Awareness Week 2022, authored by Scott Bergman, PharmD, FCCP, FIDSA, BCIDP. Read on to learn more about influential antibiotic stewardship research published this year.

November 21, 2022

Addressing Reported Penicillin Allergy – A 2022 Practice Parameter Update

This post is part of a series on Antibiotic Awareness Week 2022.  For more information about how to manage a patient reported penicillin allergy, check out the full post on the Nebraska Antimicrobial Stewardship Assessment and Promotion Program (ASAP) blog. Patient reported antibiotic allergies present clinicians with challenging decisions at the point of prescribing. Approximately […]

November 18, 2022